JUDITH RIPPERGER: Open Payments
NPI 1407071848 · WARREN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 71 payments from 13 companies in 2025. Trend: 2023 $657 · 2024 $1,101 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $330 |
| AstraZeneca Pharmaceuticals LP | 11 | $295 |
| Amgen Inc. | 12 | $155 |
| Axsome Therapeutics, Inc. | 6 | $116 |
| Exact Sciences Corporation | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Novo Nordisk Inc | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Lilly USA, LLC | 2 | $29 |
Products named: VRAYLAR, BREZTRI, OTEZLA, Auvelity, FARXIGA, REXULTI, Wegovy, QULIPTA.
Industry payments across IN — which companies pay providers there.
